BIIB021 Completed Phase 1 Trials for Malignant Lymphomas / Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00345189Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors